Pharmaceutical manufacturer will create new jobs and invest $24 million in facility expansion and new equipment
ROUND ROCK, Texas – The Round Rock Chamber today announced that Insys Therapeutics, Inc. (“Insys” or “the Company”), a specialty pharmaceutical manufacturer headquartered in Chandler, Arizona, is expanding for the third time in Round Rock. The Company is in the process of completing a 30,000 sq. ft. expansion at their 2700 Oakmont Drive location. Insys will invest $24 million in the facility and new equipment, which will enable the Company to bring on more pharmaceutical manufacturing capacity and create new jobs.
“The facility in Round Rock supports Insys by providing commercial and clinical manufacturing, and research and development capabilities for future growth,” said Insys Vice President & General Manager, Bryan Waltrip. “This expansion will provide additional jobs for the local community and contribute to the continued economic growth in this area. We are excited both as a company and as a local partner to be a part of this exciting opportunity.”
“Insys has many choices on where to expand, and it is a great testament to our community that they would choose to expand once again in Round Rock,” said Saridon Stanton, the chamber’s director of business retention and expansion.
“This type of facility is a tremendous compliment to the businesses already in the area and their expansion further develops the foundation we are building for future growth in the bioscience industry,” concluded Stanton.
About the Round Rock Chamber
The Round Rock Chamber is one of the largest and most active business organizations in Central Texas. Its approximately 1,000 investors collectively employ more than 25,000 people in the area. It is also the region’s only accredited chamber by the U.S. Chamber of Commerce. For more information, visit www.roundrockchamber.org.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients.